AltruBio has reported Phase 2a results for ALTB-268 in patients [...]

Johnson & Johnson has reported three-year clinical remission data for [...]

Abivax has reported positive topline results from Part 2 of [...]

bionyra-pharma-series-a-immunology Bionyra Pharma has launched with a $165 million Series [...]

Quotient Therapeutics and Merck sign a multi-year collaboration to identify [...]

Immunai has signed an agreement worth up to $85 million [...]

UK-based biotech N4 Pharma has announced encouraging in vivo results [...]

A new collaboration aims to tackle the toughest challenges in [...]